At Amgen, we are innovating clinical trials in ways that are improving our understanding of the natural course of disease as well as our ability to predict patient responses to the new medicines in development. The result? Shorter, smaller, more accessible studies that will yield more valuable data so we can make faster decisions and get more new, safe and effective medicines to the patients who are most likely to benefit.
What are decentralized trials?
Decentralized trials provide patients with more convenient and accessible ways to participate in clinical research.
FEATURING:
Taras Carpiac
Executive Director of Global Development Operations
